It must be noted, however, that although knockdown of LCN2 has been demonstrated to inhibit the proliferation of tumor cells in vitro [22], the feasibility of specific pharmacologic modulation of LCN2 expression in vivo with either small molecule therapeutics or biotherapeutic agents has not been demonstrated. This evidence concerns the gene LCN2 and neoplasm.